Press Releases

MOUNT LAUREL, N.J., March 26, 2020 /PRNewswire/ -- As social workers join the case management workforce in larger numbers, the Commission for Case Manager Certification® is celebrating the vital role they play in helping consumers manage the social, behavioral and environmental issues that impact consumer health. In observance of National Social Worker Mo

Morristown, N.J., March 26, 2020 /PRNewswire/ -- In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, Allergan and Bausch Health (backed by its Salix division) were ranked as the top companies best poised to deliver therapeutic innovation in the IBS market. The research was conducted in

CLINTON, Miss., March 26, 2020 /PRNewswire/ -- Across the country, in large urban areas as well as small rural communities, EMTs and paramedics are serving on the frontlines of our nation's war against the COVID-19 pandemic, oftentimes without the necessary supplies and equipment to ensure the safety of their patients and themselves.  Emergency medical service

NEW YORK, March 26, 2020 /PRNewswire/ -- Blink Fitness today announced a partnership with

SACRAMENTO, Calif., March 26, 2020 /PRNewswire/ -- Before COVID-19, California had a projected need of approximately

AUSTIN, Texas, March 26, 2020 /PRNewswire/ -- The American Association of Nurse Practitioners® (AANP), the largest association representing nurse practitioners (NPs) of all specialties, applauded action taken today by the U.S. Senate to strengthen seniors' access to home health care services and help protect health care providers by authorizin

PHILADELPHIA, March 26, 2020 /PRNewswire/ -- Kehoe Law Firm, P.C. is making in

BALERNA, Switzerland, March 26, 2020 /PRNewswire/ -- APR Applied Pharma Research s.a. ("APR"), the Swiss pharma company leveraging drug delivery technologies to develop innovative products for niche and rare diseases, today announced that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for the Company's drug candidate APR-OD031 for th

WASHINGTON, March 26, 2020 /PRNewswire/ --

PANGYO, Gyeonggi Province, Korea, March 26, 2020 /PRNewswire/ -- SK Biopharmaceuticals Co., Ltd. announced the European Medicines Agency (EMA) acceptance of Arvelle Therapeutics' Marketing Authorization Application (MAA) for cenobamate, an anti-epileptic drug (AED) for the adjunctive treatment of focal-onset (partial-onset) seizures in adults. In 2019, SK Biopharmaceuticals entered into an exclusi